Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US8026366B2 · kind B2 · utility
39Cited by
226References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2005 |
| Grant date | Sep 27, 2011 |
| Priority date | — |
| Expiry date | Nov 28, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Thiazoloquinoline and thiazolonaphthyridine compounds having an aryloxy or arylalkyleneoxy substituent at the 6-, 7-, 8-, or 9-position, pharmaceutical compositions containing the compounds, intermediates, and methods of making and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.